Colorectal cancer screening: 20 years of development and recent progress.

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F26475821%3A_____%2F14%3A%230000172" target="_blank" >RIV/26475821:_____/14:#0000172 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61383082:_____/14:#0000244 RIV/00216224:14110/14:00080133 RIV/00216208:11110/14:10227292

Výsledek na webu

<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983439/" target="_blank" >http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983439/</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3748/wjg.v20.i14.3825" target="_blank" >10.3748/wjg.v20.i14.3825</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Colorectal cancer screening: 20 years of development and recent progress.

Popis výsledku v původním jazyce

Colorectal cancer (CRC) is the second most common cancer in Europe and its incidence is steadily increasing. This trend could be reversed through timely secondary prevention (screening). In the last twenty years, CRC screening programs across Europe haveexperienced considerable improvements (fecal occult blood testing; transition from opportunistic to population based program settings). The Czech Republic is a typical example of a country with a long history of nationwide CRC screening programs in theface of very high CRC incidence and mortality rates. Each year, approximately 8000 people are diagnosed with CRC and some 4000 die from this malignancy. Twenty years ago, the first pilot studies on CRC screening led to the introduction of the opportunistic Czech National Colorectal Cancer Screening Program in 2000. Originally, this program was based on the guaiac fecal occult blood test (FOBT) offered by general practitioners, followed by colonoscopy in cases of FOBT positivity. The prog

Název v anglickém jazyce

Colorectal cancer screening: 20 years of development and recent progress.

Popis výsledku anglicky

Colorectal cancer (CRC) is the second most common cancer in Europe and its incidence is steadily increasing. This trend could be reversed through timely secondary prevention (screening). In the last twenty years, CRC screening programs across Europe haveexperienced considerable improvements (fecal occult blood testing; transition from opportunistic to population based program settings). The Czech Republic is a typical example of a country with a long history of nationwide CRC screening programs in theface of very high CRC incidence and mortality rates. Each year, approximately 8000 people are diagnosed with CRC and some 4000 die from this malignancy. Twenty years ago, the first pilot studies on CRC screening led to the introduction of the opportunistic Czech National Colorectal Cancer Screening Program in 2000. Originally, this program was based on the guaiac fecal occult blood test (FOBT) offered by general practitioners, followed by colonoscopy in cases of FOBT positivity. The prog

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

EB - Genetika a molekulární biologie

OECD FORD obor

—

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

World Journal of Gastroenterology

ISSN

1007-9327

e-ISSN

—

Svazek periodika

20

Číslo periodika v rámci svazku

14

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

10

Strana od-do

3825-3834

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—